StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC - Free Report) from a hold rating to a buy rating in a research note published on Saturday.
A number of other research analysts have also recently commented on PAHC. Barclays increased their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $21.00.
Get Our Latest Report on PAHC
Phibro Animal Health Price Performance
Shares of PAHC stock traded down $0.23 on Friday, reaching $21.62. The company's stock had a trading volume of 148,577 shares, compared to its average volume of 256,964. The company has a market capitalization of $875.67 million, a P/E ratio of 45.04, a PEG ratio of 0.45 and a beta of 0.58. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health has a 12-month low of $12.07 and a 12-month high of $26.55. The stock's 50 day simple moving average is $22.60 and its 200-day simple moving average is $22.59.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, equities analysts predict that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.22%. Phibro Animal Health's dividend payout ratio is currently 100.00%.
Institutional Trading of Phibro Animal Health
A number of institutional investors have recently modified their holdings of PAHC. Thrivent Financial for Lutherans boosted its holdings in shares of Phibro Animal Health by 23.1% during the third quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company's stock worth $468,000 after purchasing an additional 3,907 shares during the period. Segall Bryant & Hamill LLC lifted its holdings in Phibro Animal Health by 1.7% in the third quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company's stock worth $3,931,000 after buying an additional 2,971 shares during the period. Algert Global LLC lifted its holdings in Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company's stock worth $1,606,000 after buying an additional 59,850 shares during the period. FMR LLC lifted its holdings in Phibro Animal Health by 22.7% in the third quarter. FMR LLC now owns 39,310 shares of the company's stock worth $885,000 after buying an additional 7,270 shares during the period. Finally, Quantbot Technologies LP purchased a new stake in Phibro Animal Health in the third quarter worth about $70,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Further Reading
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.